OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methamphetamine-induced impulsivity during chronic methamphetamine treatment in rats: Effects of the TAAR 1 agonist RO5263397
Zhaoxia Xue, Justin N. Siemian, Bernard Johnson, et al.
Neuropharmacology (2017) Vol. 129, pp. 36-46
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Trace Amines and Their Receptors
Raul R. Gainetdinov, Marius C. Hoener, Mark D. Berry
Pharmacological Reviews (2018) Vol. 70, Iss. 3, pp. 549-620
Open Access | Times Cited: 322

Understanding Addiction Using Animal Models
Brittany N. Kuhn, Peter W. Kalivas, Ana‐Clara Bobadilla
Frontiers in Behavioral Neuroscience (2019) Vol. 13
Open Access | Times Cited: 145

Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies
Nina Dedic, Heather Dworak, Courtney Zeni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13185-13185
Open Access | Times Cited: 78

The Claustrum-Prefrontal Cortex Pathway Regulates Impulsive-Like Behavior
Jianfeng Liu, Ruyan Wu, Bernard Johnson, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 50, pp. 10071-10080
Open Access | Times Cited: 74

Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases
Michael D. Schwartz, Juan J. Canales, Riccardo Zucchi, et al.
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 6, pp. 513-526
Open Access | Times Cited: 55

TAAR Agonists
Zhengrong Xu, Qian Li
Cellular and Molecular Neurobiology (2019) Vol. 40, Iss. 2, pp. 257-272
Closed Access | Times Cited: 43

TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg
Jianfeng Liu, Jun‐Xu Li
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 38

Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review
Yazen Alnefeesi, Jocelyn K. Tamura, Leanna M.W. Lui, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 192-210
Closed Access | Times Cited: 27

TAAR1 as an emerging target for the treatment of psychiatric disorders
Jianfeng Liu, Ruyan Wu, Jun‐Xu Li
Pharmacology & Therapeutics (2023) Vol. 253, pp. 108580-108580
Closed Access | Times Cited: 11

TAARs as Novel Therapeutic Targets for the Treatment of Depression: A Narrative Review of the Interconnection with Monoamines and Adult Neurogenesis
Taisiia S. Shemiakova, Evgeniya V. Efimova, Raul R. Gainetdinov
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1263-1263
Open Access | Times Cited: 4

Characterization of serum and brain cytokine levels following prolonged binge-like methamphetamine self-administration and cued methamphetamine seeking
Amanda M. Acuña, Erin K. Nagy, Jason C. Legg, et al.
Journal of Neuroimmunology (2025) Vol. 400, pp. 578530-578530
Closed Access

Animal Models of Neurobehavioral Trait Dimensions
Evelyn Bartling-John, Kah-Chung Leong, Corinna N. Ross, et al.
(2025), pp. 29-60
Closed Access

Polydrug use patterns and their impact on relapse among heroin‐dependent patients in Shanghai, China
Tianzhen Chen, Na Zhong, Jiang Du, et al.
Addiction (2018) Vol. 114, Iss. 2, pp. 259-267
Closed Access | Times Cited: 37

Simultaneous determination of metabolic and elemental markers in methamphetamine-induced hepatic injury to rats using LC-MS/MS and ICP-MS
Yingyi Zhang, Liang Li, Qi Wang, et al.
Analytical and Bioanalytical Chemistry (2019) Vol. 411, Iss. 15, pp. 3361-3372
Closed Access | Times Cited: 33

TAAR1 and Psychostimulant Addiction
Jianfeng Liu, Ruyan Wu, Jun‐Xu Li
Cellular and Molecular Neurobiology (2020) Vol. 40, Iss. 2, pp. 229-238
Open Access | Times Cited: 32

TA 1 agonists attenuate extended‐access cocaine self‐administration and yohimbine‐induced reinstatement of cocaine‐seeking
Jianfeng Liu, Bernard Johnson, Ruyan Wu, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 15, pp. 3403-3414
Open Access | Times Cited: 22

TAAR1 and 5-HT1B receptor agonists attenuate autism-like irritability and aggression in rats prenatally exposed to valproic acid
Lien Wang, Erin Clark, Lynsey Hanratty, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 245, pp. 173862-173862
Closed Access | Times Cited: 2

Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets
Justin R. Yates
Substance Abuse and Rehabilitation (2024) Vol. Volume 15, pp. 125-161
Open Access | Times Cited: 2

Characterizing impulsivity in individuals with methamphetamine and methcathinone use disorders
Jie Yin, Xinyu Cheng, Chendi Zhou, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2

Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence
Jennifer M. Loftis, Michael Lasarev, Xiao Shi, et al.
PLoS ONE (2019) Vol. 14, Iss. 10, pp. e0220270-e0220270
Open Access | Times Cited: 20

Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention
Erik B. Oleson, Lindsey R. Hamilton, Devan M. Gomez
Frontiers in Synaptic Neuroscience (2021) Vol. 13
Open Access | Times Cited: 15

The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats
Artem Dorotenko, M. А. Tur, Antonina Dolgorukova, et al.
Cellular and Molecular Neurobiology (2019) Vol. 40, Iss. 2, pp. 215-228
Closed Access | Times Cited: 15

Behavioural and biochemical responses to methamphetamine are differentially regulated by mGlu2 and mGlu3 metabotropic glutamate receptors in male mice
Carla L. Busceti, Roxana Paula Ginerete, Luisa Di Menna, et al.
Neuropharmacology (2021) Vol. 196, pp. 108692-108692
Closed Access | Times Cited: 11

The versatile binding landscape of the TAAR1 pocket for LSD and other antipsychotic drug molecules
Kexin Jiang, You Zheng, Liting Zeng, et al.
Cell Reports (2024) Vol. 43, Iss. 7, pp. 114505-114505
Open Access | Times Cited: 1

Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders
Ruyan Wu, Jun‐Xu Li
CNS Drugs (2021) Vol. 35, Iss. 12, pp. 1239-1248
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top